Evidence for reduced hippocampal parvalbumin in schizophrenia is more sparse [5, 70], and negative reports for both regions [71–73] have led to the proposal of a ‘low GABA marker’ subgroup, comprising approximately 50% of the patient population [74]. The gene discussed is PVALB; the disease is schizophrenia.